Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.6.1.27 extracted from

  • Shaaly, A.; Kalamorz, F.; Gebhard, S.; Cook, G.M.
    Undecaprenyl pyrophosphate phosphatase confers low-level resistance to bacitracin in Enterococcus faecalis (2013), J. Antimicrob. Chemother., 68, 1583-1593.
    View publication on PubMed

Organism

Organism UniProt Comment Textmining
Enterococcus faecalis Q5WNX2
-
-

Expression

Organism Comment Expression
Enterococcus faecalis expression of is constitutive and not affected by bacitracin or cell wall-active antimicrobials additional information

General Information

General Information Comment Organism
physiological function mutants lacking enzymic activity show no significant changes in growth rate, colony morphology and biofilm formation. The mutants exhibit increased susceptibility to bacitracin. When the enzyme is expressed in a wild-type background, the minimum inhibitory concentration of bacitracin increases to 256 mg/L. The minimum inhibitory concentrations of cefoxitin, teicoplanin, vancomycin, gentamicin, enrofloxacin and D-cycloserine are unaltered in the mutant relative to the wild-type, as are susceptibilities to other stress agents such as glycine, lysozyme, NaCl, SDS, low and high pH, oxidative stress and ethanol Enterococcus faecalis